USPTO Trademark Application TM99424865 for "BECZELTEV" was filed on October 2, 2025. The mark is a standard word mark registered under Nice Classification 5, covering pharmaceutical preparations for treating cancer, autoimmune and inflammatory diseases, and infectious diseases. The application is filed under the Intent-to-Use basis, meaning the applicant has a bona fide intention to use the mark in commerce but has not yet commenced such use.

Affected parties should review whether this application conflicts with existing or pending pharmaceutical trademarks. Competitors may wish to monitor the publication of this application in the Official Gazette to file an opposition if there are grounds. The applicant will need to file a Statement of Use before registration if they proceed under the Intent-to-Use basis. No immediate compliance actions are required as this is an application-stage notice.